David Malcom Rodman

CIK: 0001672659

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)52 (44.1%)

Position reduction

Option Exercises (M)64 (54.2%)

Derivative conversions

Awards (A)2 (1.7%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

MLYS

Mineralys Therapeutics, Inc.

Officer

Discretionary Trading P&L

Holdings

Transaction History (118 total)

MLYS
Mineralys Therapeutics, Inc.
Aug 10, 2026
Sale(S)
Direct
2.2K shares at avg. $27.09$59K
MLYS
Mineralys Therapeutics, Inc.
Aug 10, 2026
Exercise(M)
Direct
2.2K shares at avg. $16.00$35K
MLYS
Mineralys Therapeutics, Inc.
Jul 17, 2026
Exercise(M)
Direct
416 shares at avg. $15.44$6K
MLYS
Mineralys Therapeutics, Inc.
Jul 17, 2026
Sale(S)
Direct
416 shares at avg. $26.53$11K
MLYS
Mineralys Therapeutics, Inc.
Jul 15, 2026
Sale(S)
Direct
6.3K shares at avg. $26.61$169K
MLYS
Mineralys Therapeutics, Inc.
Jul 13, 2026
Exercise(M)
Direct
3.5K shares at avg. $10.20$36K
MLYS
Mineralys Therapeutics, Inc.
Jul 13, 2026
Sale(S)
Direct
14.1K shares at avg. $27.58$388K
MLYS
Mineralys Therapeutics, Inc.
Jul 13, 2026
Exercise(M)
Direct
4.2K shares at avg. $14.25$59K
MLYS
Mineralys Therapeutics, Inc.
Jul 13, 2026
Exercise(M)
Direct
6.3K shares at avg. $1.08$7K
MLYS
Mineralys Therapeutics, Inc.
Jul 9, 2026
Sale(S)
Direct
2.2K shares at avg. $30.30$66K
MLYS
Mineralys Therapeutics, Inc.
Jul 9, 2026
Exercise(M)
Direct
2.2K shares at avg. $16.00$35K
MLYS
Mineralys Therapeutics, Inc.
Jun 17, 2026
Sale(S)
Direct
4.6K shares at avg. $25.00$115K
MLYS
Mineralys Therapeutics, Inc.
Jun 17, 2026
Exercise(M)
Direct
417 shares at avg. $15.44$6K
MLYS
Mineralys Therapeutics, Inc.
Jun 17, 2026
Exercise(M)
Direct
4.2K shares at avg. $14.25$59K
MLYS
Mineralys Therapeutics, Inc.
Jun 15, 2026
Sale(S)
Direct
9.9K shares at avg. $23.81$235K
MLYS
Mineralys Therapeutics, Inc.
Jun 15, 2026
Exercise(M)
Direct
3.5K shares at avg. $10.20$36K
MLYS
Mineralys Therapeutics, Inc.
Jun 12, 2026
Sale(S)
Direct
6.3K shares at avg. $23.93$152K
MLYS
Mineralys Therapeutics, Inc.
Jun 12, 2026
Exercise(M)
Direct
6.3K shares at avg. $1.08$7K
MLYS
Mineralys Therapeutics, Inc.
Jun 10, 2026
Exercise(M)
Direct
2.2K shares at avg. $16.00$35K
MLYS
Mineralys Therapeutics, Inc.
Jun 10, 2026
Sale(S)
Direct
2.2K shares at avg. $25.00$54K
MLYS
Mineralys Therapeutics, Inc.
May 18, 2026
Sale(S)
Direct
417 shares at avg. $27.55$11K
MLYS
Mineralys Therapeutics, Inc.
May 18, 2026
Exercise(M)
Direct
417 shares at avg. $15.44$6K
MLYS
Mineralys Therapeutics, Inc.
May 13, 2026
Sale(S)
Direct
14.1K shares at avg. $28.58$402K
MLYS
Mineralys Therapeutics, Inc.
May 13, 2026
Exercise(M)
Direct
3.5K shares at avg. $10.20$36K
MLYS
Mineralys Therapeutics, Inc.
May 13, 2026
Exercise(M)
Direct
4.2K shares at avg. $14.25$59K

		Type	Shares	Price		Ownership
Aug 10, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	2,170	$27.09	$58,785	Direct
Aug 10, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	2,170	$16.00	$34,720	Direct
Jul 17, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	416	$15.44	$6,423	Direct
Jul 17, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	416	$26.53	$11,036	Direct
Jul 15, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	6,349	$26.61	$168,955	Direct
Jul 13, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	3,542	$10.20	$36,128	Direct
Jul 13, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	14,058	$27.58	$387,717	Direct
Jul 13, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	4,167	$14.25	$59,380	Direct
Jul 13, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	6,349	$1.08	$6,857	Direct
Jul 9, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	2,171	$30.30	$65,781	Direct
Jul 9, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	2,171	$16.00	$34,736	Direct
Jun 17, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	4,584	$25.00	$114,600	Direct
Jun 17, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	417	$15.44	$6,438	Direct
Jun 17, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	4,167	$14.25	$59,380	Direct
Jun 15, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	9,890	$23.81	$235,487	Direct
Jun 15, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	3,542	$10.20	$36,128	Direct
Jun 12, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	6,349	$23.93	$151,901	Direct
Jun 12, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	6,349	$1.08	$6,857	Direct
Jun 10, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	2,170	$16.00	$34,720	Direct
Jun 10, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	2,170	$25.00	$54,250	Direct
May 18, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	417	$27.55	$11,488	Direct
May 18, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	417	$15.44	$6,438	Direct
May 13, 2026	MLYS Mineralys Therapeutics, Inc.	Sale(S)	14,056	$28.58	$401,789	Direct
May 13, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	3,541	$10.20	$36,118	Direct
May 13, 2026	MLYS Mineralys Therapeutics, Inc.	Exercise(M)	4,166	$14.25	$59,366	Direct

1-25 of 118 transactions

About Rodman David Malcom

Rodman David Malcom (SEC CIK 0001672659) files insider reports with the SEC as Chief Medical Officer of Mineralys Therapeutics, Inc. (MLYS).

Signal8 holds 40 ownership filings by Rodman David Malcom, all Form 4s, filed between Sep 12, 2024 and Aug 12, 2026. Those filings report 118 transactions, from Sep 11, 2024 to Aug 10, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Rodman David Malcom's filings is in RADNOR, PA.

Recent filings by Rodman David Malcom

Aug 10, 2026: Open-market sale of MLYS shares (Form 4, code S).
Aug 10, 2026: Option exercise of MLYS shares (Form 4, code M).
Jul 17, 2026: Option exercise of MLYS shares (Form 4, code M).
Jul 17, 2026: Open-market sale of MLYS shares (Form 4, code S).
Jul 15, 2026: Open-market sale of MLYS shares (Form 4, code S).

Other insiders filing for Mineralys Therapeutics, Inc. (MLYS)

Peterson Kristine, Director
COATS LONNEL, Director
Congleton Jon, Chief Executive Officer
Slingsby Brian Taylor, Director
Warren Eric, Chief Commercial Officer
Karydas Daphne, Director

How to read Form 4 transaction codes